Υπήρξε ένα πρόβλημα κατά τη φόρτωση αυτής της σελίδας.
Η ομάδα μας έχει ειδοποιηθεί, αλλά επικοινωνήστε μαζί μας χρησιμοποιώντας το widget υποστήριξης email εάν το πρόβλημα παραμένει.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | Yes |
| Is net profit margin increasing? | Yes | Yes |
| Is asset turnover increasing? | Yes | No |
| Is equity multiplier increasing? | Yes | Yes |
| Competitors Used |
|---|
| SK bioscience Co.,Ltd. |
| SK Biopharmaceuticals Co., Ltd. |
| Hugel, Inc. |
| Genome & Company |
| Genexine, Inc. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| A302440 | A326030 | A145020 | A314130 | A095700 | A196170 | |||
| Return On Equity | ||||||||
| Latest Twelve Months | -3% | 58% | 14% | -56% | -17% | 41% | ||
| Fiscal Year - 1 | 1% | -11% | 8% | -55% | -14% | -2% | ||
| Fiscal Year - 2 | 7% | -37% | 7% | -33% | -9% | -6% | ||
| Fiscal Year - 3 | 22% | 16% | 6% | -86% | 7% | -6% | ||
| Fiscal Year - 4 | NA | -135% | 6% | 213% | -6% | -24% | ||
| Fiscal Year - 5 | NA | -314% | 10% | NA | NA | -1% | ||
| Average | 7% | -70% | 8% | -3% | -8% | 0% | ||
| Median | 4% | -24% | 8% | -55% | -9% | -4% | ||
| Benchmarks | Ticker | |||||||
| SK bioscience Co.,Ltd. | KOSE:A302440 | |||||||
| SK Biopharmaceuticals Co., Ltd. | KOSE:A326030 | |||||||
| Hugel, Inc. | KOSDAQ:A145020 | |||||||
| Genome & Company | KOSDAQ:A314130 | |||||||
| Genexine, Inc. | KOSDAQ:A095700 | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | A302440 | A326030 | A145020 | A314130 | A095700 | A196170 | ||
| Latest Fiscal Year | Dec-24 | Dec-24 | Dec-23 | Dec-23 | Dec-23 | Dec-24 | ||
| LTM Period | Dec-24 | Dec-24 | Sep-24 | Sep-24 | Mar-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 267,545 | 547,596 | 363,785 | 24,090 | 5,808 | 102,855 | ||
| Fiscal Year | 267,545 | 547,596 | 319,700 | 14,296 | 4,427 | 102,855 | ||
| Fiscal Year - 1 | 369,506 | 354,892 | 281,675 | 14,085 | 16,139 | 96,523 | ||
| Fiscal Year - 2 | 456,726 | 246,179 | 231,859 | 451 | 36,828 | 28,806 | ||
| Fiscal Year - 3 | 929,001 | 418,645 | 211,038 | 151 | 18,543 | 38,746 | ||
| Fiscal Year - 4 | NA | 25,999 | 204,568 | 46 | 11,303 | 42,426 | ||
| Fiscal Year - 5 | NA | 123,852 | 182,392 | NA | NA | 29,229 | ||
| Net Income | ||||||||
| Latest Twelve Months | (53,881) | 240,738 | 112,044 | (35,671) | (54,525) | 60,690 | ||
| Fiscal Year | (53,881) | 240,738 | 93,076 | (47,466) | (66,874) | 60,690 | ||
| Fiscal Year - 1 | 22,318 | (32,883) | 60,558 | (51,838) | (55,974) | (3,372) | ||
| Fiscal Year - 2 | 122,452 | (139,431) | 56,506 | (34,117) | (48,042) | (8,146) | ||
| Fiscal Year - 3 | 355,139 | 64,846 | 41,992 | (30,732) | 27,570 | (6,275) | ||
| Fiscal Year - 4 | NA | (247,414) | 44,612 | (84,669) | (16,509) | (15,822) | ||
| Fiscal Year - 5 | NA | (71,519) | 69,736 | NA | NA | (705) | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 1,852,439 | 723,171 | 991,543 | 180,531 | 439,855 | 256,100 | ||
| Latest Fiscal Quarter | 2,843,596 | 1,036,811 | 942,960 | 151,774 | 365,387 | NA | ||
| Fiscal Year | 2,843,596 | 1,036,811 | 929,251 | 162,060 | 376,587 | NA | ||
| Fiscal Year - 1 | 1,852,439 | 723,171 | 1,049,783 | 172,997 | 388,781 | 256,100 | ||
| Fiscal Year - 2 | 2,141,931 | 664,241 | 1,009,737 | 137,216 | 636,865 | 245,490 | ||
| Fiscal Year - 3 | 2,110,123 | 643,652 | 956,344 | 120,883 | 596,908 | 258,319 | ||
| Fiscal Year - 4 | NA | 500,241 | 894,690 | 35,185 | 358,177 | 159,207 | ||
| Fiscal Year - 5 | NA | 139,073 | 918,266 | NA | NA | 85,979 | ||
| Fiscal Year - 6 | NA | 95,536 | 820,930 | NA | NA | 71,381 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 1,703,855 | 283,686 | 785,586 | 76,138 | 336,858 | 148,114 | ||
| Latest Fiscal Quarter | 1,802,565 | 546,273 | 817,080 | 50,584 | 288,066 | NA | ||
| Fiscal Year | 1,802,565 | 546,273 | 747,310 | 61,708 | 296,622 | NA | ||
| Fiscal Year - 1 | 1,703,855 | 283,686 | 792,112 | 96,360 | 272,641 | 148,114 | ||
| Fiscal Year - 2 | 1,741,702 | 316,560 | 777,085 | 92,733 | 513,928 | 148,311 | ||
| Fiscal Year - 3 | 1,601,312 | 444,187 | 746,674 | 111,434 | 535,605 | 133,974 | ||
| Fiscal Year - 4 | NA | 379,067 | 699,496 | (39,676) | 296,909 | 61,248 | ||
| Fiscal Year - 5 | NA | (13,025) | 727,720 | NA | NA | 69,982 | ||
| Fiscal Year - 6 | NA | 58,629 | 695,710 | NA | NA | 66,080 | ||